saplin

Compare funds

Axis Midcap vs DSP Midcap

Both are mid cap funds. Over the last 3 years Axis Midcap returned 16.9% a year and DSP Midcap 13.5%, against a category median of 16.4%. Axis Midcap costs 0.77% a year and DSP Midcap 0.83%. On the saplin Score Axis Midcap rates 7.7 (Neutral) and DSP Midcap 6.0 (Neutral) within their category. 40.4% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

Axis MidcapDSP MidcapCategory median
saplin Score (0–10)7.7 Neutral6.0 Neutral—
1-year return7.6%2.4%4.9%
3-year return, a year16.9%13.5%16.4%
5-year return, a year12.3%10.9%14.3%
Volatility (standard deviation)16.5%18.5%18.3%
Sharpe ratio0.670.470.62
Beta0.840.960.95
Upside capture909698
Downside capture759990
Expense ratio (Direct)0.77%0.83%0.94%
Fund size₹34,576 cr₹20,510 cr₹7,096 cr
Number of holdings856374
Top 10 holdings, share of fund26.5%29.6%27.5%
Portfolio P/E45.332.434.1
Lead managerShreyash Devalkar (10 yrs)Vinit Sambre (14 yrs)—
Launched18 Feb 201114 Nov 2006—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

Axis Midcap and DSP Midcap have 40.4% of their portfolios in the same stocks (34 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsAxis MidcapDSP Midcap
The Federal Bank4.27%2.83%
Fortis Healthcare2.62%2.96%
The Phoenix Mills2.34%2.85%
IPCA Laboratories2.32%2.94%
Multi Commodity Exchange of India2.14%3.30%
Eternal2.23%1.91%
ICICI Bank1.83%2.09%
Coforge1.79%4.92%
Bharat Forge1.69%2.80%
Alkem Laboratories1.37%1.75%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.